# Heterogeneity in preoperative Staphylococcus aureus screening and decolonization strategies among healthcare institutions

**Authors:** Sarah L. Bennis, Shalini Kulasingam, Patricia Ferrieri, Susan E. Kline

PMC · DOI: 10.1017/ice.2024.231 · 2025-01-27

## TL;DR

This study examines how different healthcare institutions screen and treat Staphylococcus aureus in patients before surgery.

## Contribution

The study reveals significant variability in screening and decolonization practices across institutions.

## Key findings

- Institutions use universal, targeted, or no decolonization strategies.
- Commonly used products include nasal mupirocin and chlorhexidine gluconate bathing.
- Practice variability suggests a need for standardized optimal strategies.

## Abstract

We surveyed 111 institutions’ practices for screening and decolonization of Staphylococcus aureus in presurgical patients. Institutions commonly utilize universal, targeted, or no decolonization strategies. Frequently reported products were nasal mupirocin, chlorhexidine gluconate bathing, and nasal povidone-iodine. Practice variability indicates opportunities to define optimal strategies.

## Linked entities

- **Chemicals:** mupirocin (PubChem CID 446596), chlorhexidine gluconate (PubChem CID 9552081), povidone-iodine (PubChem CID 410087)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11883650/full.md

---
Source: https://tomesphere.com/paper/PMC11883650